Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
Pharmacotherapy|May 10, 2025
Proton pump inhibitor concomitant use to prevent oxaliplatin-induced peripheral neuropathy: Clinical retrospective cohort studyKeisuke Mine, Takehiro Kawashiri, Kohei Mori, et al.
Anticancer Research|March 29, 2022
Usefulness of Medication Guidance Sheets for Patients With Non-Hodgkin's Lymphoma Receiving ESHAP±R TherapyMayako Uchida, Saeko Murata, Hanae Morikawa, et al.
Cureus|February 4, 2025
Self-Organizing Map-Based Assessment of Immune-Related Adverse Events Caused by Immune Checkpoint InhibitorsSatoshi Nakao, Koumi Miyasaka, Mika Maezawa, et al.
Biological & Pharmaceutical Bulletin|May 8, 2013
Effectiveness and safety of antiemetic aprepitant in Japanese patients receiving high-dose chemotherapy prior to autologous hematopoietic stem cell transplantationMayako Uchida, Hiroaki Ikesue, Toshihiro Miyamoto, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|February 28, 2023
Efficacy and safety of mycophenolate mofetil in treating immune-related hepatitis induced by immune checkpoint inhibitor use: A retrospective studyYukio Kadokawa, Satoko Inoue, Akitoshi Tatsumi, et al.
Pharmacotherapy|May 29, 2013
Efficacy and safety of aprepitant in allogeneic hematopoietic stem cell transplantationMayako Uchida, Koji Kato, Hiroaki Ikesue, et al.
Biological & Pharmaceutical Bulletin|February 9, 2013
Decrease in venous irritation by adjusting the concentration of injected bendamustineHiroyuki Watanabe, Hiroaki Ikesue, Tomoko Tsujikawa, et al.
Clinical Nutrition (Edinburgh, Scotland)|January 31, 2026
Prospective study of anamorelin in pancreatic cancer cachexia: Clinical and translational insights into response heterogeneityRyosuke Matsukane, Haruna Minami, Nao Fujimori, et al.
The Annals of Pharmacotherapy|June 15, 2014
Time Course of Calcium Concentrations and Risk Factors for Hypocalcemia in Patients Receiving Denosumab for the Treatment of Bone Metastases From CancerHiroaki Ikesue, Toshikazu Tsuji, Koujiro Hata, et al.
Pageof 11